Previous work showed that higher expression of total IL-33 and ST2 correlates with CRC progression and metastasis, with inhibition of IL-33 in CRC cells resulting in reduced cell migration, colony formation and tumor growth in vitro, and smaller tumors in vivo [72, 73]. The gene discussed is IL33; the disease is colorectal carcinoma.